Skip to content

Clinical trials

Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Clear all

1,168 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20017
200210
200317
200422
200529
200647
200765
200858
200949
201047
201139
201256
201341
201457
201567
201634
201738
201849
201955
202045
202150
202255
202346
202440
202564
202649

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed667
Unknown status158
Recruiting107
Terminated107
Not yet recruiting42
Active, not recruiting39
Withdrawn37
Enrolling by invitation8
Suspended2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)54
Novartis Pharmaceuticals43
Bayer22
Notal Vision Ltd.21
Medical University of Vienna18
Alcon Research16
Allergan15
Pfizer14
Genentech, Inc.13
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration1,168
Choroidal Neovascularization132
Geographic Atrophy115
Diabetic Retinopathy94
Retinal Diseases70
Retinal Vein Occlusion56
Wet Macular Degeneration55
Eye Diseases53
Retinal Degeneration52
Vision Disorders46

Trials

Showing 1 to 25 of 1,168. Each trial links to its page on Pharma Observatory.

1,068 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.